At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 21, 2026 at 16:00 ET
Trevi Therapeutics is holding its 2026 annual meeting where shareholders will vote on several proposals including electing a director, ratifying auditors, approving executive compensation, amending the stock incentive plan, and increasing authorized shares. This is a routine annual shareholder meeting.
- Annual meeting to vote on director election, auditor ratification, executive compensation, stock incentive plan amendment, and share authorization
- Board recommends voting for all proposals
- Meeting date: June 3, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access